John Hart, MD
Ophthalmology · West Bloomfield, MINPI 1780675363
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.8%), food and beverage and entertainment — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Alcon at 55.6% of the total. 2025 is the largest year on record at $3,216, 2.4 times the $1,367 reported in 2019. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $59.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$6K
- Bausch & Lomb Americas Inc.$2K
- AbbVie$893
- Sun Pharmaceutical Industries Inc.$357
- Johnson & Johnson Surgical Vision, Inc.$286
- Ivantis, Inc$156
- plus $926 from 14 others
What the payments were for
- Travel & lodging$6,41458%
- Food & beverage$4,62242%
- Entertainment$561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 32 | $6,169 |
| Bausch & Lomb Americas Inc. | 30 | $2,306 |
| AbbVie(2 entities) | 60 | $893 |
| Sun Pharmaceutical Industries Inc. | 19 | $357 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $286 |
| Ivantis, Inc | 2 | $156 |
| Novartis | 8 | $141 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $124 |
| NEW World Medical,inc. | 5 | $101 |
| Harrow Eye, LLC | 4 | $99 |
| Tarsus Pharmaceuticals, Inc. | 4 | $93 |
| Glaukos Corporation | 2 | $64 |
| Optos, Inc. | 1 | $56 |
| Shire North American Group Inc | 3 | $54 |
| Amgen(2 entities) | 2 | $42 |
| Thea Pharma Inc. | 2 | $39 |
| Dompe US, Inc. | 2 | $39 |
| Eyevance Pharmaceuticals LLC | 3 | $38 |
| Rxsight Inc | 1 | $22 |
| Aerie Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis IOL$244
- NGENUITY$226
- Clareon$140
- Hydrus Microstent$132
- TECNIS Presbyopia-Correcting IOLs$124
How this compares
$11,092 in reported general payments places this provider in the 90th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 114 | $63,318 |
| RestasisCyclosporine | 19 | $21,276 |
| Cyclosporine | 35 | $17,566 |
| CombiganBrimonidine Tartrate/Timolol | 26 | $15,941 |
| Prednisolone Acetate | 422 | $13,109 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 52 | $12,266 |
| Latanoprost | 294 | $5,126 |
| Brimonidine Tartrate | 74 | $4,852 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 95 | $4,605 |
| Travoprost | 22 | $4,328 |
| Timolol Maleate | 142 | $2,994 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 13 | $2,841 |
| Ketorolac Tromethamine | 117 | $2,101 |
| Ciprofloxacin Hcl | 180 | $2,042 |
| Bimatoprost | 11 | $1,633 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan | $893 | $100,535159 claims |
| AlconSimbrinza | $6,169 | $2,84113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 674 ophthalmology providers in Michigan.
Other ophthalmology in West Bloomfield
- Manjool ShahAnn Arbor$609K
- Gregory KatzYpsilanti$401K
- Timothy PageBirmingham$250K
- David ZacksAnn Arbor$177K
- Scott WesthouseGrand Rapids$138K
- Bret HughesDetroit$123K
- Pradeepa YoganathanDetroit$115K
- Jason MillerAnn Arbor$104K
- David TukelDearborn$91K
- Yannis PaulusAnn Arbor$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.